Biotech firm set to rise: TFN Hot Stock Pick of the Week Video
Posted May 22, 2008
Baltimore — (TFN): The development of cutting-edge biologic drugs that are already improving – even saving – lives marks Osiris Therapeutics as a winner among biotech stocks. Their multi-purpose wonder-drug Prochymal is set to be the first FDA approved stem cell therapy.
Watch the Today’s Financial News video.
****Make sure you sign up for our FREE TFN News Feed for breaking news, special reports and new financial videos. Click here to pick your favorite reader. If you prefer to have the feed delivered to your email, just click here.
Related Articles
- Hot Stock Pick of the Week: Buy this discount retailer now - February 14, 2008
- A steady stock in volatile times: The TFN Hot Stock Pick of the Week Video - April 17, 2008
- TFN Hot Stock Pick of Week Video: A diamond in a mud pit - April 3, 2008
- This Stock to Get the Gold: The TFN Hot Stock Pick of the Week Video - April 9, 2008
- This bargain stock set to grow: A TFN Smart Trading Video - May 1, 2008


TFN provides an independent and practical perspective on the U.S. and global investment markets.
Add New Comment
Thanks. Your comment is awaiting approval by a moderator.
Do you already have an account? Log in and claim this comment.
Add New Comment